Cargando…
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
BACKGROUND: The threat of a possible Marburg virus disease outbreak in Central and Western Africa is growing. While no Marburg virus vaccines are currently available for use, several candidates are in the pipeline. Building on knowledge and experiences in the designs of vaccine efficacy trials again...
Autores principales: | Longini, Ira M, Yang, Yang, Fleming, Thomas R, Muñoz-Fontela, César, Wang, Rui, Ellenberg, Susan S, Qian, George, Halloran, M Elizabeth, Nason, Martha, Gruttola, Victor De, Mulangu, Sabue, Huang, Yunda, Donnelly, Christl A, Henao Restrepo, Ana-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679315/ https://www.ncbi.nlm.nih.gov/pubmed/35866633 http://dx.doi.org/10.1177/17407745221110880 |
Ejemplares similares
-
Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic
por: Madewell, Zachary J, et al.
Publicado: (2021) -
Pygmy Populations Seronegative for Marburg Virus
por: Borchert, Matthias, et al.
Publicado: (2005) -
Serosurvey on Household Contacts of Marburg Hemorrhagic Fever Patients
por: Borchert, Matthias, et al.
Publicado: (2006) -
COVID-19 vaccine trials: The use of active controls and non-inferiority studies
por: Fleming, Thomas R, et al.
Publicado: (2021) -
An introduction to the Marburg virus vaccine consortium, MARVAC
por: Cross, Robert W., et al.
Publicado: (2022)